SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-004130 to Definitive Healthcare Corp. (DH) (CIK 0001861795) (DH)

Definitive Healthcare Corp. (DH) (CIK 0001861795)
Date: April 25, 2023 · CIK: 0001861795 · Accession: 0000000000-23-004130

AI Filing Summary & Sentiment

File numbers found in text: 001-40815

Date
April 24, 2023
Author
Not clearly detected
Form
UPLOAD
Company
Definitive Healthcare Corp. (DH) (CIK 0001861795)

Letter

United States securities and exchange commission logo April 24, 2023 Richard Booth Chief Financial Officer Definitive Healthcare Corp. 492 Old Connecticut Path, Suite 401 Framingham, MA 01701 Re:Definitive Healthcare Corp. Form 10-K for the Fiscal Year ended December 31, 2022 Filed February 27, 2023 File No. 001-40815 Dear Richard Booth: We have limited our review of your filing to the financial statements and related disclosures and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response. After reviewing your response to these comments, we may have additional comments. Form 10-K for the Fiscal Year Ended December 31, 2022 Management's Discussion and Analysis of Financial Condition and Results of Operations Non-GAAP Financial Measures, page 48 1.We note that you reconcile from gross profit to the non-GAAP Adjusted Gross Profit measure, although also present Adjusted Gross Margin, representing Adjusted Gross Profit as a percentage of revenue, without a comparable GAAP measure.

Please expand your discussion and analysis to present with equal or greater prominence a corresponding gross margin percentage based on your GAAP measure of gross profit to comply with Item 10(e)(1)(i) of Regulation S-K. Results of Operations, page 53 2.We note that you identify multiple factors associated with changes in revenue and cost of revenue for 2022 without quantifying the changes attributable to each factor.

FirstName LastNameRichard Booth Comapany NameDefinitive Healthcare Corp. April 24, 2023 Page 2 FirstName LastName Richard Booth Definitive Healthcare Corp. April 24, 2023 Page 2

For example, in discussing revenue you state that the increase was "...primarily due to net expansion with existing customers, as well as organic additions of new customers, and the addition of new customers resulting from the acquisition of Analytical Wizards;" and in discussing cost of revenue you state that the increase was "...primarily due to increased data and hosting fees, increases in employee benefit and insurance costs and, to a lesser extent, incremental personnel costs resulting from the acquisition of Analytical Wizards, partially offset by lower amortization of acquired technology costs."

We believe that you should address changes in your results of operations in both qualitative and quantitative terms to comply with Item 303(b) of Regulation S-K; this would ordinarily require quantification of each material factor, including offsetting factors, that are reflected in the line items being discussed.

The guidance in subparagraphs (b)(2)(i) and (iii) further clarify that this should include the effects of unusual or infrequent events or transactions and significant economic changes that materially affected income from continuing operations; and the extent to which material changes in revenues are attributable to changes in prices, changes in the volumes of goods or services sold, and to the introduction of new products or services.

Please submit the revisions that you propose to address the aforementioned guidance.

In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Jenifer Gallagher, Staff Accountant at (202) 551-3706 or John Cannarella, Staff Accountant at (202) 551-3337 with any questions. Sincerely, Division of Corporation Finance Office of Energy & Transportation

Show Raw Text
United States securities and exchange commission logo
April 24, 2023
Richard Booth
Chief Financial Officer
Definitive Healthcare Corp.
492 Old Connecticut Path, Suite 401
Framingham, MA 01701
Re:Definitive Healthcare Corp.
Form 10-K for the Fiscal Year ended December 31, 2022
Filed February 27, 2023
File No. 001-40815
Dear Richard Booth:
            We have limited our review of your filing to the financial statements and related
disclosures and have the following comments.  In some of our comments, we may ask you to
provide us with information so we may better understand your disclosure.
            Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
            After reviewing your response to these comments, we may have additional comments.
Form 10-K for the Fiscal Year Ended December 31, 2022
Management's Discussion and Analysis of Financial Condition and Results of Operations
Non-GAAP Financial Measures, page 48
1.We note that you reconcile from gross profit to the non-GAAP Adjusted Gross Profit
measure, although also present Adjusted Gross Margin, representing Adjusted Gross
Profit as a percentage of revenue, without a comparable GAAP measure.

Please expand your discussion and analysis to present with equal or greater prominence
a corresponding gross margin percentage based on your GAAP measure of gross profit to
comply with Item 10(e)(1)(i) of Regulation S-K.
Results of Operations, page 53
2.We note that you identify multiple factors associated with changes in revenue and cost of
revenue for 2022 without quantifying the changes attributable to each factor.

 FirstName LastNameRichard Booth
 Comapany NameDefinitive Healthcare Corp.
 April 24, 2023 Page 2
 FirstName LastName
Richard Booth
Definitive Healthcare Corp.
April 24, 2023
Page 2

For example, in discussing revenue you state that the increase was "...primarily due to net
expansion with existing customers, as well as organic additions of new customers, and the
addition of new customers resulting from the acquisition of Analytical Wizards;" and in
discussing cost of revenue you state that the increase was "...primarily due to increased
data and hosting fees, increases in employee benefit and insurance costs and, to a lesser
extent, incremental personnel costs resulting from the acquisition of Analytical Wizards,
partially offset by lower amortization of acquired technology costs."

We believe that you should address changes in your results of operations in both
qualitative and quantitative terms to comply with Item 303(b) of Regulation S-K; this
would ordinarily require quantification of each material factor, including offsetting
factors, that are reflected in the line items being discussed.

The guidance in subparagraphs (b)(2)(i) and (iii) further clarify that this should include the
effects of unusual or infrequent events or transactions and significant economic changes
that materially affected income from continuing operations; and the extent to which
material changes in revenues are attributable to changes in prices, changes in the volumes
of goods or services sold, and to the introduction of new products or services.

Please submit the revisions that you propose to address the aforementioned guidance.

            In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            You may contact Jenifer Gallagher, Staff Accountant at (202) 551-3706 or John
Cannarella, Staff Accountant at (202) 551-3337 with any questions.
Sincerely,
Division of Corporation Finance
Office of Energy & Transportation